Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026)
Syndax Pharmaceuticals' Revenue came in at $72.79 million for Q2 2026, up 91.8% from $37.96 million a year earlier and up 12.2% from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Revenue (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Syndax Pharmaceuticals reported Revenue of $252.25 million, up 222.7% year-over-year; for FY2025, it was $172.35 million, up 627.8% from FY2024.
- Revenue carries a five-year compound annual growth rate of 157.7% (FY2020 to FY2025).
- Going back by year, Revenue was $23.68 million in FY2024 and $139.71 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Revenue since Q4 2021.
- Year-over-year, Revenue has increased for five consecutive quarters, with growth averaging 472.4% over the last five quarters.
- Business Quant data shows SNDX's Revenue at $64.86 million (Q1 2026), $68.73 million (Q4 2025) and $45.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Syndax Pharmaceuticals | 1.63 Bn | -103.87 Mn | 69.58 Mn | 72.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.79 Mn |
| Mar 31, 2026 | 64.86 Mn |
| Dec 31, 2025 | 68.73 Mn |
| Sep 30, 2025 | 45.87 Mn |
| Jun 30, 2025 | 37.96 Mn |
| Mar 31, 2025 | 20.04 Mn |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Dec 31, 2021 | 126.58 Mn |
| Sep 30, 2021 | 12.38 Mn |
| Jun 30, 2021 | 379,000.00 |
| Mar 31, 2021 | 379,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Sep 30, 2020 | 379,000.00 |
| Jun 30, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Sep 30, 2019 | 379,000.00 |
| Jun 30, 2019 | 379,000.00 |
API Access
Syndax Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();